kanamycin a has been researched along with Meningitis, Viral in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brückner, O; Collmann, H; Hoffmann, HG | 1 |
| Sluga, W; Sluga-Gasser, E; Spitzy, KH | 1 |
2 other study(ies) available for kanamycin a and Meningitis, Viral
| Article | Year |
|---|---|
[CSF levels of amikacin following systemic application in patients with slightly and severely impaired blood cerebrospinal barrier (author's transl)].
Topics: Adult; Aged; Amikacin; Blood-Brain Barrier; Humans; Kanamycin; Meningitis; Meningitis, Viral; Middle Aged | 1982 |
[Inflammatory diseases of the nervous system. Therapy of encephalitis and myelitis].
Topics: Actinomycosis; Ampicillin; Anticonvulsants; Antifungal Agents; Antimalarials; Arbovirus Infections; Bacteria; Brain Edema; Cephalosporins; Chloramphenicol; Encephalitis; Encephalitis Viruses; Encephalomyelitis; Erythromycin; Ethionamide; Herpesviridae Infections; Humans; Kanamycin; Meningitis, Viral; Meningococcal Infections; Meningoencephalitis; Methicillin; Mycoses; Myelitis; Oxacillin; Penicillins; Polymyxins; Protozoan Infections; Rickettsia Infections; Streptomycin; Sulfonamides; Tetracycline; Tuberculosis, Meningeal | 1969 |